5基甲基氨酸沉积调解了在MYCN - 放大神经母细胞瘤中聚合体抑制复合体2的功能
bioRxiv : the preprint server for biology
|July 17, 2025
概括
在MYCN增强神经母细胞瘤中,Polycomb Repressive Complex 2 (PRC2) 目标基因上显示了5-基甲基氨酸 (5-hmC) 的增加. 这种与H3K27me3的共同定位抑制了发育基因,提供了治疗洞察力.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 发展生物学 发展生物学
背景情况:
- MYCN放大是神经母细胞瘤预后不佳的关键驱动因素,神经母细胞瘤是一种常见的儿科癌症.
- 了解MYCN增强神经母细胞瘤的表观遗传情景对于开发向疗法至关重要.
研究的目的:
- 研究MYCN增强神经母细胞瘤中5-基甲基细胞素 (5-hmC) 沉积的作用.
- 探索5-hmC和多抑制复合体2 (PRC2) 的表观遗传标记之间的相互作用.
主要方法:
- 在神经母细胞瘤瘤中分析5-hmC和H3K27me3的同位点.
- 研究抑制5-hmC沉积的功能后果.
- 评估PRC2抑制对基因表达和药物敏感性的影响.
主要成果:
- 增强MYCN的神经母细胞瘤在PRC2基因上呈现增加的5-hmC,在核细胞水平上有5-hmC和H3K27me3的直接同定位.
- 由5-hmC/H3K27me3标记的基因参与发育途径,并被转录抑制.
- 5-hmC的抑制导致H3K27me3的损失,并使神经母细胞瘤对去甲基化剂敏感.
- 在PRC2抑制后激活的5-hmC原始H3K27me3标记基因.
结论:
- 5-hmC和H3K27me3合作抑制MYCN增强神经母细胞瘤中的发育基因.
- 这种表观遗传相互作用代表了一种新的机制,将DNA和染色质修饰联系起来.
- 准这种途径对神经母细胞瘤治疗有潜在的治疗意义.
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
01:46Epigenetic Regulation
31.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.4K
02:23Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
01:29Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
02:30Genomic Imprinting and Inheritance
35.3K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.3K